Package Leaflet: Information for the User
FRENADOL?Decongestant Hard Capsules
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
FRENADOL? Decongestant is an association of paracetamol that reduces fever and relieves pain, dextromethorphan that is a cough suppressant, chlorphenamine that helps reduce nasal secretion and sneezing, and pseudoephedrine that relieves nasal congestion.
This medicine is indicated for the symptomatic relief of colds and flu that present with mild or moderate pain such as headache, fever, unproductive cough (irritative cough, nervous cough), nasal secretion, and congestion, and sneezing for adults and adolescents from 12 years old.
You should consult your doctor if your condition worsens or does not improve after 5 days of treatment in adults or 3 days in adolescents, or if the fever persists for more than 3 days, or if the cough is accompanied by rash or persistent headache.
Do not take FRENADOL?Decongestant
Warnings and Precautions
You should consult your doctor or pharmacist before starting to take FRENADOL? Decongestant:
Patient with a persistent respiratory condition such as emphysema, chronic bronchitis, bronchial asthma, or cough accompanied by excessive secretions, glaucoma, prostatic hyperplasia with residual urine formation, is recommended to consult a doctor before using this product.
During treatment with FRENADOL? Decongestant, inform your doctor immediately if:
If you have severe diseases, such as severe kidney failure or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you have malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A serious disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling of discomfort (nausea) and vomiting.
With Frenadol Decongestant, blood flow to the optic nerve may be reduced. If you experience sudden vision loss, stop taking Frenadol Decongestant and contact your doctor or seek immediate medical attention. See section 4.
This medicine may cause dependence. Therefore, treatment should be short-term. Special caution is recommended in adolescents and young adults, as well as in patients with a history of drug abuse or use of psychoactive substances.
This medicine may produce sedation. Avoid consuming alcoholic beverages and certain medicines while being treated with this medicine, as they may potentiate this effect. Consult the sections "Taking FRENADOL? Decongestant with other medicines" and "Taking FRENADOL? Decongestant with food, beverages, and alcohol".
Patient over 60 years old may be especially sensitive to the adverse effects of the medicine because it contains pseudoephedrine, which is a sympathomimetic amine. Overdose of sympathomimetic amines in these patients, over 60 years old, can cause hallucinations, central nervous system depression, convulsions, and death.
Sedated, debilitated, or bedridden patients should not take this medicine.
In rare cases, severe skin reactions with redness, blisters, or rashes may occur. If you notice any of these symptoms, discontinue treatment and consult your doctor.
It is recommended not to take this medicine at the same time as other medicines for cough or nasal congestion. Consult "Taking FRENADOL? Decongestant with other medicines".
If you are going to undergo surgery, you should discontinue treatment with this medicine at least 24 hours in advance.
Children
Children under 12 years old cannot take this medicine due to the dose of its active ingredients.
Taking FRENADOL?Decongestant with other medicines
Inform your doctor or pharmacist if you are taking or have recently taken or may need to take any other medicine.
In particular, if you are using any of the following medicines, it may be necessary to modify the dose of some of them or interrupt treatment:
Interference with analytical tests:
If you are going to undergo any diagnostic tests (including blood tests, urine tests, skin tests that use allergens, etc...), inform your doctor that you are taking this medicine, as it may alter the results.
While taking this medicine, you cannot consume alcoholic beverages, as it may potentiate the appearance of adverse effects of this medicine.
Additionally, the use of medicines that contain paracetamol by patients who habitually consume alcohol (3 or more alcoholic beverages: beer, wine, liquor,... per day) may cause liver damage.
You should not take this medicine with grapefruit or bitter orange juice, as it may potentiate the adverse effects of some of its components, dextromethorphan and pseudoephedrine.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. The use of medicines during pregnancy can be hazardous for the embryo or fetus and should be monitored by your doctor.
This medicine is contraindicated in the first trimester of pregnancy and should not be taken during the remaining period of pregnancy unless your doctor considers it strictly necessary.
The 4 active ingredients of this medicine are excreted in breast milk; therefore, breastfeeding women should not take FRENADOL? Decongestant unless the benefits of treatment for the mother outweigh the possible risks for the infant.
Driving and Using Machines
FRENADOL? Decongestant may produce sedation. If you notice these effects, avoid driving vehicles or using machines.
Follow the administration instructions of the medicine contained in this prospectus or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults: 1 capsule every 6 or 8 hours (3 or 4 times a day), as needed. Preferably take 1 capsule before bedtime. Do not take more than 4 capsules (equivalent to 2 g of paracetamol) per day. See section "Warnings and precautions".
Adolescents between 12 and 18 years: 1 capsule every 6 or 8 hours (3 or 4 times a day) as needed. Preferably take 1 dose before bedtime. Do not exceed 4 doses (equivalent to 2 g of paracetamol) per day.
Patient with liver failure: Must consult with their doctor. The recommended dose is 1 capsule every 8 hours. Do not take more than 4 capsules (equivalent to 2 g of paracetamol) per day.
Patient with kidney failure: Consult with your doctor. The recommended dose is 1 capsule every 6 or 8 hours, depending on the degree of kidney failure.
Use in children
Use in people over 60 years
People over 60 years are often more prone to the stimulating effects of one of the components of this medicine (pseudoephedrine), so sometimes the dose should be reduced. Consult with your doctor.
How to take
It is taken orally.
Take the capsule with the help of a glass of water.
Always use the smallest effective dose.
Treatment will be discontinued as symptoms disappear.
Consult your doctor if symptoms worsen or if symptoms persist after 5 days of treatment in adults or 3 days in adolescents, or if fever persists for more than 3 days, or if cough is accompanied by rash or persistent headache.
If you take more FRENADOL?Decongestant than you should
Go immediately to a medical center, even if there are no symptoms, since they often do not manifest until 3 days after ingestion of the overdose, even in cases of severe poisoning.
The most serious effect of overdose of the medicine is liver damage caused by paracetamol. You may feel dizziness, confusion, excitability, restlessness, nervousness, irritability, insomnia, dilation of the pupils, anxiety, agitation, hallucinations, tremors, convulsions, difficulty urinating, gastrointestinal upset, abdominal pain, feeling of general discomfort, nausea and vomiting, loss of appetite, rapid breathing and difficulty breathing, increased blood pressure, palpitations, alteration of heart rhythm (arrhythmias), tachycardia and reflex bradycardia, visual disturbances, yellowing of the skin and eyes (jaundice). In children, states of drowsiness or alterations in gait. In more severe cases, it can cause: decrease in potassium in the blood (hypokalemia), mental disorder with altered perception of reality (psychosis), convulsions, coma, hypertensive crisis, arrhythmias, cerebral hemorrhage, myocardial infarction, rhabdomyolysis, and intestinal ischemic infarction.
Other symptoms in case of massive overdose may be: coma, severe respiratory problems, and convulsions.
Contact your doctor or hospital immediately if you experience any of the mentioned symptoms.
There have been reports of abuse of medicines containing dextromethorphan, with the possibility of serious adverse effects such as agitation, confusion, conversion disorder, mixed hallucinations, ataxia (uncoordinated movements), clumsiness, coma, decreased level of consciousness, dysarthria (alteration in the articulation of words), dystonia, lethargy, nystagmus (involuntary and uncontrolled movement of the eyes), convulsions, serotonin syndrome (neuromuscular disorders), tremors, miosis, mydriasis (pupil dilation), respiratory depression, urinary retention, tachycardia, hypertension, and ischemic colitis.
Overdose of pseudoephedrine can cause nausea, vomiting, sympathomimetic symptoms, including stimulation of the central nervous system, insomnia, tremors, mydriasis, anxiety, agitation, hallucinations, convulsions, palpitations, tachycardia, hypertension, and reflex bradycardia (slowdown of heartbeats). Other effects may include arrhythmias, hypertensive crisis, cerebral hemorrhage, myocardial infarction, psychosis, rhabdomyolysis (breakdown of muscle tissue), hypokalemia, and intestinal ischemic infarction. Drowsiness has been reported in overdose in children.
Treatment of overdose is most effective if started within 4 hours after ingestion of the medicine. Patients undergoing treatment with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
In case of overdose or accidental ingestion, go immediately to a medical center or, if not possible, consult the Toxicology Information Service (telephone: 91 5620420), indicating the medicine and the amount ingested.
Like all medicines, FRENADOL? Decongestant may cause adverse effects, although not all people suffer from them.
Frequency not known: cannot be estimated from available data
Stop using FRENADOL? Decongestant immediately and seek urgent medical attention if you present symptoms that may be signs of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). These include:
The most frequent adverse effects are sedation and somnolence. The following adverse effects were reported in at least 1 in 100 subjects during clinical trials with chlorphenamine, chlorphenamine/paracetamol/pseudoephedrine/ single ingredient pseudoephedrine and paracetamol/pseudoephedrine: Asthenia, dizziness, dry mouth, dyspepsia, restlessness, insomnia, nausea, nervousness, pharyngitis, and somnolence.
During the period of use of the association of paracetamol, chlorphenamine, dextromethorphan, and pseudoephedrine, the following other adverse effects have occurred, whose frequency cannot be established with precision:
Severe allergic reactions, such as anaphylactic reaction, hypersensitivity, anxiety, euphoric mood, hallucinations, visual hallucinations, restlessness, stroke, headache, tingling and numbness in the limbs, nervousness and nervousness (psychomotor hyperactivity), tremors, arrhythmia, myocardial infarction, palpitations, tachycardia, abdominal pain, ischemic colitis, diarrhea, vomiting, severe skin reaction (acute generalized exanthematous pustulosis), angioedema (swelling of certain areas of the skin), pruritus, urticaria, rash, pruritic rash, skin lesions after taking the medicine (fixed drug eruption), acute generalized exanthematous pustulosis, dysuria (difficulty urinating), and urinary retention. With the same frequency, general disorders such as irritability, increased blood pressure, increased transaminases, and decreased blood flow to the optic nerve (ischemic optic neuropathy).
The simultaneous consumption of alcohol during treatment may increase the appearance of adverse effects. Do not ingest alcoholic beverages during the same.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines. Website: www.notificaram.es
Keep this medicine out of sight and reach of children.
Do not store at a temperature above 30°C.
Do not use this medicine after the expiration date indicated on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines that are no longer needed in the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that are no longer needed. This will help protect the environment.
The active ingredients are: paracetamol 500 mg, chlorphenamine 2 mg (as maleate), dextromethorphan 15 mg (as hydrobromide), and pseudoephedrine 30 mg (as hydrochloride)
The other components (excipients) are: pregelatinized cornstarch, colloidal silicon dioxide, magnesium stearate, gelatin, erythrosine (E-127), quinoline yellow (E-104), titanium dioxide (E-171), black iron oxide (E-172)
Appearance of the product and package contents
They are hard gelatin capsules, red and white opaque, with the name "Frenadol decongestant" serigraphed.
Each package contains 16 capsules.
Marketing authorization holder | Manufacturer |
JNTL Consumer Health (Spain), S.L. Pº de las Doce Estrellas, 5-7 28042 Madrid Spain | LUSOMEDICAMENTA SOCIEDADE TECNICA FARMACEUTICA, S.A. Estrada Consiglieri Pedroso, nº69 B – Queluz de Baixo 2730-055 Bacarena-Portugal |
Date of the last revision of this prospectus:February 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/